Klinischer Newsletter

    Klinischer Newsletter

    Für regelmmäßige Updates zu unseren neusten Studien:

    Jetzt Anmelden

    Publikationssuche

    Unsere Forschungs- und Entwicklungsteams sind weltweit im Einsatz und generieren Synergien aus unserem Expertenwissen und verwandten Fachdisziplinen. Wir stehen im internationalen Austausch mit unabhängigen Fachinstitutionen, Key Opinion Leadern und Multiplikatoren, um so Kooperations- und Wissensmanagement auf höchstem Niveau gewährleisten zu können. Im Rahmen dessen führen wir umfangreiche Forschungen durch, die kontinuierlich auf Kongressen in Form von Postern oder freien Vorträgen unserer Kooperationspartner sowie in Symposien und Workshops präsentiert und in namhaften wissenschaftlichen Fachzeitschriften veröffentlicht werden. Die größtenteils von unabhängigen Gutachtern bewerteten, evidenzbasierten Fachpublikationen, stellen wir Ihnen in dieser Datenbank zur Verfügung:

    1. Journal article

      Chronic oedema in patients with CVI and ulceration of the lower limb

      British journal of community nursing 2009 14 (10) 46 8

      Patients with chronic venous insufficiency and ulceration can have additional problems with chronic oedema, if a combination of venous and lymphatic insufficiency is present. Standard leg ulcer bandaging systems may not be suitable for reducing chronic oedema. This article provides the opportunity for practitioners to learn more about oedema in patients with CVI and to reflect on their current bandaging practice.

      Products Mollelast
      PMID 19966695
    2. Journal article

      Development and implementation of a clinical pathway to improve venous leg ulcer treatment

      Wounds : a compendium of clinical research and practice 2009 21 (5) 127 133

        A clinical pathway (CP) was developed and implemented to improve treatment outcomes for patients with venous leg ulcers. The CP and products (Rosidal® sys, Suprasorb® A, Suprasorb® P, and Suprasorb® C, Lohmann & Rauscher GmbH, Rengsdorf, Germany) were tested by case evaluation. Patients from the center were examined to determine his or her general condition, associated factors, wound type and stage, wound evolution, quality of life (QOL), treatment efficacy, and costs. Patients with venous leg ulceration (N = 20) were recruited to the clinical evaluation. Examination was performed upon presentation, and then at 2-week intervals for 12 weeks. The patients were then followed until ulcer closure. The outcome of the study group (SG) was compared to the results of a randomly selected patient control group (CG) at the center before implementing the clinical pathway. Statistic evaluation was performed using StatXact 5.0, double sided (α = 0.05) for paired and Wilcoxon test, and unpaired with Mann-Whitney (N = 20, [10/10]). After implementation, a statistically significant (P < 0.005) shorter period for ulcer closure was demonstrated for the SG when compared to previous treatment given to the CG. In the SG, 5/10 ulcers closed within 12 weeks versus 3/10 in the CG. An improvement in QOL was noted for the SG (P < 0.05 for the combined parameters, and P < 0.005 for pain), as well as cost savings (P < 0.05). The CP applied throughout the complete care chain improved quality of treatment outcomes and made effective use of resources and materials.

      PMID 25903321
    3. Poster

      Cost-effectiveness in Modern Wound Management Observation study with an HydroBalance biocellulose based wound dressing* in Germany

      Poster presented at WoundsUK 2008 10.11.2008 Harrogate, UK
      Further languages
    4. Poster

      First Italian experience with a polihexanide-containing HydroBalanced wound dressing* in hospitalized patients with critically-colonized or infected chronic wounds

      Poster presented at WoundsUK 2008 10.11.2008 Harrogate, UK
      Further languages
    5. Poster

      Comparison of the binding capacity of collagen from different origin for IL-1b and TNF-a

      Poster presented at WoundsUK 2008 10.11.2008 Harrogate, UK
      Further languages
    6. Poster

      The in vitro formation of ROS/RNS is inhibited by polihexanide

      Poster presented at WoundsUK 2008 10.11.2008 Harrogate, UK
      Further versions
      Further languages
    7. Poster

      Successful therapy of critically-colonised or locally infected wounds with a new HydroBalanced biocellulose-based wound dressing* with polihexanide on out-patients

      Poster presented at WoundsUK 2008 10.11.2008 Harrogate, UK
      Further versions
      Further languages
    8. Poster

      HydroBalanced wound dressing* and a ready-to-wear compression device** in the treatment of venous leg ulcers

      Poster presented at WoundsUK 2008 10.11.2008 Harrogate, UK
      Products Suprasorb X
      Further versions
      Further languages
    9. Poster

      ESPERIENZA CLINICA CONDOTTA SU 40 CASI NEL TRATTAMENTO DI ULCERE AGLI ARTI INFERIORI CON UNA MEDICAZIONE IN BIOCELLULOSA A TECNOLOGIA HYDROBALANCE*

      Poster presented at AIUC 2008 24.09.2008 Rome, Italy
    10. Poster

      Applicazione di una medicazione in biocellulosa a tecnologia HydroBalance + PHMB * in una ustione da piastra da elettrobisturi in cardiochirurgia

      Poster presented at AIUC 2008 24.09.2008 Rome, Italy